Ameriprise
VERA icon

Ameriprise’s Vera Therapeutics VERA Stock Holding History

Ameriprise’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$602K Sell
14,973
-168
-1% -$7.24K ﹤0.01% 3514
2025
Q4 		$767K Buy
15,141
+55
+0.4% +$1.95K ﹤0.01% 3455
2025
Q3 		$438K Sell
15,086
-2,302
-13% -$53.2K ﹤0.01% 3671
2025
Q2 		$410K Sell
17,388
-6,361
-27% -$143K ﹤0.01% 3593
2025
Q1 		$570K Sell
23,749
-6,272
-21% -$202K ﹤0.01% 3435
2024
Q4 		$1.27M Buy
30,021
+7,227
+32% +$320K ﹤0.01% 3131
2024
Q3 		$1.01M Sell
22,794
-792
-3% -$30.1K ﹤0.01% 3219
2024
Q2 		$853K Buy
23,586
+12,602
+115% +$500K ﹤0.01% 3216
2024
Q1 		$474K Buy
+10,984
New +$391K ﹤0.01% 3437

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise's VERA Position: Q1 2026 in Review

Ameriprise reduced its Vera Therapeutics (VERA) stake by 1.1% in Q1 2026, selling an estimated $7.24K and leaving 14,973 shares worth $602K. The position accounts for ﹤0.01% of the portfolio, ranked #3514.

Ameriprise first reported a position in VERA in Q1 2024 and has held it in 9 quarters since. The position peaked at $1.27M in Q4 2024. 229 funds tracked by Wall St. Rank hold VERA as of Q1 2026.

  • Ameriprise held 14,973 shares of Vera Therapeutics worth $602K as of Q1 2026.
  • Ameriprise sold 168 Vera Therapeutics shares in Q1 2026, an estimated $7.24K.
  • Vera Therapeutics made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #3514 holding.
  • Ameriprise first reported a position in Vera Therapeutics in Q1 2024 and has held it in 9 quarters since.
  • Ameriprise's Vera Therapeutics position peaked at $1.27M in Q4 2024.
  • 229 funds tracked by Wall St. Rank held Vera Therapeutics as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.